27-Mar-2024
No press releases found.
Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
Benzinga (Tue, 26-Mar 10:30 PM ET)
The Fund is concentrated in any industry or group of industries in the health care sector, including, in particular, issuers having their principal business activities in the biotechnology industry. Other industries in the health care sector include medical laboratories and research, drug manufacturers and agricultural chemicals.
Ark Genomic Revolution ETF trades on the ARCA stock market under the symbol ARKG.
As of March 27, 2024, ARKG stock price climbed to $28.55 with 1,118,434 million shares trading.
ARKG has a beta of 2.39, meaning it tends to be more sensitive to market movements. ARKG has a correlation of 0.52 to the broad based SPY ETF.
ARKG has a market cap of $1.59 billion. This is considered a Small Cap stock.
In the last 3 years, ARKG stock traded as high as $94.14 and as low as $21.97.
ARKG has underperformed the market in the last year with a price return of -0.3% while the SPY ETF gained +33.9%. ARKG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.2% and -3.1%, respectively, while the SPY returned +10.3% and +1.5%, respectively.
ARKG support price is $27.22 and resistance is $28.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARKG stock will trade within this expected range on the day.